Xeris Biopharma Holdings, Inc. (FRA:2B30)
Germany · Delayed Price · Currency is EUR 5.87
+0.02 (0.34%)
At close: Dec 19, 2025
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of €1.04 billion as of December 19, 2025. Its market cap has increased by 105.65% in one year.
Market Cap
1.04B
Enterprise Value
1.18B
Revenue
226.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.87
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 256.47M to 1.04B, an increase of 305.25%. That is a compound annual growth rate of 39.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.04B | 112.91% |
| Dec 31, 2024 | 488.15M | 66.23% |
| Dec 29, 2023 | 293.66M | 73.53% |
| Dec 30, 2022 | 169.23M | -47.33% |
| Dec 31, 2021 | 321.29M | 25.28% |
| Oct 6, 2021 | 256.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |